Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate
- 1 March 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 43 (5) , 1013-1019
- https://doi.org/10.1016/0006-2952(92)90607-k
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Biochemical modulation of cisplatin toxicityPharmacology & Therapeutics, 1989
- Effect of Sodium Thiosulfate on the Pharmacokinetics and Toxicity of CisplatinJNCI Journal of the National Cancer Institute, 1989
- Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapyPharmacology & Therapeutics, 1988
- Pharmacokinetics of WR-2721Pharmacology & Therapeutics, 1988
- The mechanism of action of platinum antitumor drugsPure and Applied Chemistry, 1987
- Inhibition of cis-diamminedichloroplatinum (II) ? induced renal toxicity in the ratCancer Chemotherapy and Pharmacology, 1986
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721International Journal of Radiation Oncology*Biology*Physics, 1984
- A simple method for the inactivation of monofunctionally DNA-bound cis- diamminedichloroplatinum (II)Journal of Inorganic Biochemistry, 1984
- Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamideBritish Journal of Cancer, 1980